News Contact Us

Janssen begins phase 3 trials of its potential COVID-19 vaccine in U.K.

Author : Pankaj Singh | Published Date : 2020-11-17 

According to reliable sources, Belgium-based multinational pharmaceutical company, Janssen Pharmaceutica has reportedly initiated the administration and enrolment of participants for the phase 3 clinical trials of its potential COVID-19 vaccine candidate.

If sources are to be believed, the investigational drug, which is modelled on the Ebola vaccine, will be initially tested on 6000 participants from 17 locations across the United Kingdom including Southampton, Leicester, Dundee, Cardiff, Bristol and Belfast. Moreover, a total of 24,000 volunteers will be recruited from other countries.

For the record, the placebo-controlled trials will investigate the efficacy and safety of the potential coronavirus vaccine by introducing a weakened common cold virus. The virus will apparently spike the coronavirus proteins in the cells of the candidates, which will in turn trigger an immune response.

It is to be noted that the phase 1 and 2 trials of Janssen’s vaccine revealed that the investigational drug induces a robust immune response and is well-tolerated by a majority of the candidates.

Sources close to the matter claimed that around 25,000 Britons have participated in the clinical trials for the potential COVID-19 vaccine and more than 310,000 individuals have agreed to sign up to the NHS (National Health Service) vaccine research registry.

Chairman of the U.K. vaccine taskforce, Kate Bingham was reported saying that although the recent development is highly encouraging, the department will continue to focus towards the research of the safety and efficacy of COVID-19 vaccine.

Saul Faust, principal investigator of the clinical trials and professor of pediatric immunology and infectious diseases at the University of Southampton mentioned in a statement that there is a high demand for volunteers who are at a great risk for contracting the Coronavirus, primarily frontline health and social care workers and individuals from the Asian, African and other minority communities.

If the phase 3 trials conclude the efficacy and safety of the investigational vaccine, the U.K. government will reportedly administer around 30 million doses of the drug by the first half of 2021.

Source credits: https://www.theguardian.com/world/2020/nov/16/6000-uk-volunteers-to-be-injected-with-covid-vaccine-in-phase-3-trial

About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

No-deal Brexit would cost UK more than COVID-19, warns BoE Governor

Published Date: 2020-11-25         Author: Pankaj Singh

Bank of England Governor, Andrew Bailey, has reportedly warned that the economic cost of a no-deal Brexit would be much more significant in the long haul than the one caused by the COVID-19 pandemic. Bailey stated that failure to finalize a deal prior to the expiration of the Brexit transition by... Read More

Bega to raise $400 million to buy Lion Dairy and Drinks business

Published Date: 2020-11-24         Author: Pankaj Singh

Bega Cheese, a leading Australian diversified food company, reportedly looks set to include yogurt in its product portfolio after beating Tanarra Capital and global dairy giant, Saputo Inc., in the bid to buy-out the Lion Dairy and Drinks business. The deal, valued at $550 million, is currently i... Read More

Israel orders 10 million doses of AstraZeneca’s COVID-19 vaccine

Published Date: 2020-11-23         Author: Pankaj Singh

The Government of Israel has reportedly signed a new agreement to purchase 10 million doses of the COVID-19 vaccine developed by the Oxford University. This new announcement was jointly made in a statement by the pharmaceutical firm AstraZeneca, who is producing the vaccine, and the Israeli governme... Read More

© 2020 Fractovia. All Rights Reserved